SCM
RDY icon

Stevens Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Stevens Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-49,260
Closed -$400K – 351
2019
Q4 		$400K Buy
+49,260
New +$389K 0.04% 392
2017
Q3 		– Sell
-36,630
Closed -$309K – 1035
2017
Q2 		$309K Buy
+36,630
New +$298K 0.01% 671
2017
Q1 		– Sell
-86,075
Closed -$779K – 1065
2016
Q4 		$779K Buy
+86,075
New +$801K 0.03% 480

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Stevens Capital Management's RDY Position: Q1 2020 in Review

Stevens Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2020, closing a stake of 49,260 shares — an estimated $400K sold.

Stevens Capital Management first reported a position in RDY in Q4 2016 and held it in 3 quarters. The position peaked at $779K in Q4 2016. 148 funds tracked by Wall St. Rank hold RDY as of Q1 2020.

  • Stevens Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2020 after selling out during the quarter.
  • Stevens Capital Management sold 49,260 Dr. Reddy's Laboratories shares in Q1 2020, an estimated $400K.
  • Stevens Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2016 and held it in 3 quarters.
  • Stevens Capital Management's Dr. Reddy's Laboratories position peaked at $779K in Q4 2016.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2020.

Based on Stevens Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.